Evidence map›Paper›PMID 41748911›Full record

ArticleNPJ digital medicine2026

A device-invariant multi-modal learning framework for respiratory disease classification.

Mo Yang, Xuefei Liu, Wei Du, Yang Liu, Wenyu Zhu, Zhaoyang Bu, Jiaxuan Mao, Qian Wang, Si Chen, Min Zhou and 1 more

Abstract read
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mo YangResearch&Development Department, Luca Healthcare, Shanghai, China.
Xuefei Liu *Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Wei Du *Department of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Yang LiuResearch&Development Department, Luca Healthcare, Shanghai, China.
Wenyu ZhuResearch&Development Department, Luca Healthcare, Shanghai, China.
Zhaoyang BuResearch&Development Department, Luca Healthcare, Shanghai, China.
Jiaxuan MaoResearch&Development Department, Luca Healthcare, Shanghai, China.
Qian WangResearch&Development Department, Luca Healthcare, Shanghai, China. qian.wang173@hotmail.com.
Si ChenResearch&Development Department, Luca Healthcare, Shanghai, China. echo.chen@lucahealthcare.com.
Min ZhouDepartment of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. doctor_zhou_99@163.com.
Jie-Ming QuDepartment of Pulmonary and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. jmqu0906@163.com.

Funding

National Key R&D Program of China 2022YFC2010005
6 · The paper itself

Abstract

Recent advances in cough sound analysis using deep learning techniques enable smartphone-based respiratory disease screening suitable for self-management care in a home setting, yet their utility is limited by device heterogeneity, population diversity, and challenges in multimodal integration. We propose a device-invariant, multimodal deep learning framework that jointly models cough acoustics, demographic data, and symptom descriptions for multi-label classification of adult respiratory diseases. To address the issues of device effect, an adversarial branch is embedded in the audio encoder to enforce device-invariant feature learning, while an invariant risk minimization-augmented loss enhances robustness to non-structural shifts. To evaluate the effectiveness of our proposed method, a real-world, multi-center dataset containing over 10,000 cases spanning seven major respiratory conditions was curated. On the tasks of individual respiratory disease identification for chronic obstructive pulmonary disease (COPD), lower respiratory tract infection (LRTI) and pulmonary shadows (PS), our method achieves superior performance with the area under the receiver operating characteristic curve (AUROC) of 0.9698, 0.8483 and 0.8720, respectively. It also shows promising results in identifying the presence of comorbidities for 7 respiratory diseases with an overall AUROC of 0.8907. More importantly, extensive experimental results demonstrate our method mitigates the issues of device effect and facilitates the cross-device generalization for cough-based respiratory disease diagnoses. This work demonstrates a scalable and transferable AI-based approach for cough-driven respiratory screening, emphasizing the importance of multimodal fusion and robust representation learning in advancing clinical applicability.

Identifiers

PMID41748911
PMCPMC13061893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.